This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Elgan Pharma Ltd. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations in Insulin Formulations by Stav Zeldis
Introduction
Stav Zeldis is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of medical formulations, particularly in the area of insulin for preterm infants. His innovative approach has the potential to improve the health outcomes of vulnerable populations.
Latest Patents
Stav Zeldis holds a patent for "Insulin formulations and methods of using same in preterm infants." This patent describes an insulin formulation that includes insulin, oligosaccharide, and sodium chloride in a specific ratio of 1:A:B (w:w:w). The ranges for A and B are defined as 1000-5000 and 10-50, respectively. This formulation aims to enhance the efficacy of insulin treatment in preterm infants.
Career Highlights
Stav Zeldis is currently associated with Elgan Pharma Ltd., where he continues to work on innovative solutions in pharmaceutical formulations. His expertise in insulin formulations has positioned him as a key player in the medical research community.
Collaborations
Stav collaborates with talented professionals such as Michal Olshansky and Elena Ostrovsky. Their combined efforts contribute to the advancement of medical technologies and formulations.
Conclusion
Stav Zeldis's work in insulin formulations represents a significant advancement in pediatric medicine. His innovative approach and collaboration with skilled colleagues highlight the importance of research in improving healthcare for preterm infants.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile